To specifically investigate the conclusion that high E2F activity serves as a biomarker for sensitivity to KDM6B inhibition in neuroblastoma, we categorized neuroblastoma cell lines into two groups according to their IC50 to GSK-J443. Here, KDM6B is linked to neuroblastoma.